Brought to you by 
AZ enters unique partnership with the Medical Research Council, academia
31 Oct 2012
Executive Summary
AstraZeneca PLC has joined forces with the Medical Research Council (MRC) to grant to various UK academic institutions free access to 22 of AZ’s discontinued drug projects. The Big Pharma retains rights to all chemical composition IP and commercial rights to the original compounds.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AZ enters unique partnership with the Medical Research Council, academia
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice